Seika Inoue1, Enrique Alvarez2, Carrie M. Hersh3, Derrick Robertson4, Ayan Das Gupta5, Xixi Hu6, Ronald Zielman7, Ibolya Boer8, Andy Cheadle6, Jeffrey A. Cohen9 (1.Novartis Pharma K.K., Japan, 2.University of Colorado School of Medicine, Aurora, CO, USA, 3.Cleveland Clinic Mellen Program for MS, Lou Ruvo Center for Brain Health, Las Vegas, NV, USA, 4.Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, USA, 5.Novartis Healthcare Pvt. Ltd., Hyderabad, India, 6.Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 7.Novartis Pharma B.V., Amsterdam, Netherlands, 8.Novartis Pharma AG, Basel, Switzerland, 9.Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA)
Session information
Japanese Poster Session
[Pj-017] Japanese Poster Session 017
Wed. May 31, 2023 5:20 PM - 6:40 PM Poster (幕張メッセ国際展示場 1F 展示ホール7)
Chair:Okamoto Tomoko (National Center Hospital, NCNP, Japan)
Ryoko Shibuya1, Mamoru Yamamoto1, Hirofumi Konishi2, Koji Ishikuro3, Takamasa Nukui1, Noriaki Hattori4, Yuji Nakatsuji1 (1.Department of Neurology, Toyama University Hospital, Japan, 2.Toyama Prefectural Rehabilitation Hospital & Support Center for Children with Disabilities, Japan, 3.Department of Rehabilitation, Toyama University Hospital, Japan, 4.Department of Rehabilitation, Toyama University Hospital, Japan)
Satoru Oji, Yoshihiro Furukawa, Masaomi Yamamoto, Baku Hashimoto, Atsuo Miyauchi, Wataru Hara, Kazunari Monma, Tomohisa Dembo, Manabu Araki, Hikoaki Fukaura, Kyoichi Nomura, Ken-ichi Kaida (Neurology, Saitama Medical Center, Saitama Medical University, Japan)
Jun Shinmi1, Atsuko Katsumoto1,2, Wakiro Sato2,3, Youwei Lin1,2, Tomoko Okamoto1,2, Takashi Yamamura2,3, Yuji Takahashi1 (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Multiple Sclerosis Center, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 3.Immunology Department, Institute of Neuroscience, National Center Hospital, National Center of Neurology and Psychiatry, Japan)
Hikaru Kamiya, Nana Suzuki, Tomohiro Uemura, Shiori Kikuchi, Kohei Kano, Tsukasa Saito, Jun Sawada, Naoki Nakagawa (asahikawa medical university, Japan)
Takahiro Terauchi1, Masanori Mizuno2, Manami Maeta1, Masako Suzuki1, Tetsuya Maeda1 (1.Iwate medical university department of Neurology, Japan, 2.Saiseikai utunomiya hospital department of Neurology, Japan)